Faculty Disclosures of Relevant Financial Relationships

All relevant financial relationships have been mitigated.

Presenter Disclosures

• Katelyn Atkins, MD, PhD, is employed by Cedars-Sinai Medical Center. Dr. Atkins receives grant/research funding (institution) from Varian Medical Systems. 
• Christopher A. Barker, MD, is employed by Memorial Sloan Kettering Cancer Center. Dr. Barker receives grant/research funding (institution) from EMD Serono and Elekta. Dr. Barker receives grant/research funding and Advisory Board role honoraria/travel expenses from Regeneron.  
• Jose Bazan, MD, MS, is employed by City of Hope and has no relevant financial relationships to disclose.
• Lauren Henke, MD, MS, is employed by University Hospitals. Dr. Henke receives grant/research funding, honoraria and compensation/payment from Varian Medical Systems. Dr. Henke receives Advisory Board role compensation/payment from Elekta.
• Kimberly Johung, MD, PhD, is employed by Yale University School of Medicine and has no relevant financial relationships to disclose. 
• Michelle Kim, MD, is employed by the University of Michigan and has no relevant financial relationships to disclose. 
• Amar Kishan, MD, is employed by UCLA. Dr. Kishan receives Consultant role honoraria from Varian Medical Systems and Boston Scientific. Dr. Kishan receives grant/research funding (institution) from Janssen, Inc., Point BioPharma and ViewRay Systems and grant/research funding (individual) from Lantheus and Novartis. Dr. Kishan has ownership equity in MiraDx.
• Lilie Lin, MD, FASTRO, is employed by the University of Texas MD Anderson Cancer Center. Dr. Lin receives grant/research funding (institution) from AstraZeneca, Pfizer and Varian. 
• Sean McBride, MD, MPH, is employed by Memorial Sloan Kettering Cancer Center and has no relevant financial relationships to disclose. 
• Andrea Ng, MD, MPH, FASTRO, is employed by Massachusetts General Brigham and has no relevant financial relationships to disclose. 
• Nitin Ohri, MD, MS, is employed by Albert Einstein College of Medicine, Montefiore Medical Center. Dr. Ohri receives grant/research funding (institution) from AstraZeneca, Regeneron and Koneksa. Dr. Ohri serves in an uncompensated role as a principal investigator for Shanghai Henlius Biotech and BeOne Medicines.    
• Ravi Patel, MD, PhD, is employed by the University of Pittsburgh Hillman Cancer Center. Dr. Patel receives grant/research funding (institution) from Voximetry and Merck. Dr. Patel received Advisory Board role compensation/payment from GE Healthcare [relationship ended November 2025].
• Neil K. Taunk, MD, MSCTS, is employed by the University of Pennsylvania. Dr. Taunk receives honoraria, travel expenses and compensation/payment from Boston Scientific for Advisory Board, Consultant and Education/Meeting Faculty roles. Dr. Taunk receives grant/research funding, honoraria and compensation/payment from Point BioPharma/Eli Lilly for Advisory Board and Consultant roles. Dr. Taunk receives grant/research funding (institution) from Varian Medical Systems. Dr. Taunk receives honoraria from Novartis and honoraria and travel expenses from GE Healthcare for Advisory Board and Consultant roles. Dr. Taunk received honoraria and travel expenses from GenMab Pharmaceuticals for a Speaker Bureau role [relationship ended May 2024].
• Nicholas Zaorsky, MD, MS, is employed by University Hospitals and has no relevant financial relationships to disclose. 

Planner/Moderator Disclosures

• Megan Daly, MD, is employed by the University of California, Irvine. Dr. Daly receives grant/research funding (institution) from Genentech and honoraria from AstraZeneca. Dr. Daly received grant/research funding (institution) from Merck [relationship ended December 2025] and honoraria from Dava [relationship ended October 2024]; Novocure [relationship ended November 2024]; and Bristol Myers Squibb [relationship ended November 2024].
• Sue Yom, MD, PhD, FASTRO, is employed by the University of California, San Francisco. Dr. Yom receives grant/research funding (institution) from Bristol Myers Squibb, EMD Serono and Johnson & Johnson.  

Reviewer Disclosure

• Michael Haddock, MD is employed by the Mayo Clinic and has no relevant financial relationships to disclose.